Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Seahorse Bioscience, a manufacturer of instruments and consumables for cell-based metabolic assays, has acquired BioProcessors, a manufacturer of systems for optimizing biologic drug manufacturing. The two companies will be integrated and operate under the Seahorse name.
Subscribe to our email newsletter
A concurrent $6 million financing included Commonwealth Capital, Oxford Bioscience, Flagship Ventures, Life Sciences Partners, FLIR Systems, Healthcare Ventures, New Science Ventures and HLM Venture Partners.
Jay Teich, CEO of Seahorse Bioscience, said: “Our sales of XF series instruments tripled in 2008, and we introduced three new products to this market at the end of the year. With the addition of the people and technologies of BioProcessors, we will expand and grow the SimCell product line and markets during the coming year.”